Table of Contents
Ready to See Results?
From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.
The Headline Operators Missed
The biggest behavioral health story of October 2024 is not a deal or a defendant. It is the MHPAEA Final Rule. On September 9, 2024, the Departments of Labor, Health and Human Services, and Treasury issued final rules implementing the Mental Health Parity and Addiction Equity Act, and by late October operators were still figuring out what it meant for their contracts. The short version: plans must produce their NQTL comparative analysis within ten business days of a DOL or HHS request, and within thirty days of a participant request. That reshapes every managed care contracting conversation an operator will have in 2025.
I saw the panic in real time. A COO in Florida called me the second week of October, three months into a payer dispute over residential authorizations, asking whether the new rule gave her any teeth. It did. It always did. Operators just did not know how to use it.
Why the Parity Rule Actually Matters at the Facility Level
Read the preamble. The Departments cited a RTI International study finding out-of-network use was 3.5 times higher for behavioral health clinician office visits than for medical/surgical office visits, and concluded the gap was not fully explained by workforce shortages. Regulators are telling you, in writing, that they believe payers have built networks designed to fail. That is not consultant hyperbole. That is the federal record.
Then look at what the rule requires. Plans must evaluate network composition, out-of-network reimbursement rates, and prior authorization NQTLs, and cannot use standards designed to disfavor mental health or substance use disorder benefits. If you are an ASAM Level 3.5 residential operator in Georgia getting denied on day seven while medical/surgical inpatient reviews run past ten, that is now a documented parity signal. Operators who track their concurrent review denial data at the CPT level are the ones who will win better contracts in 2025.
One note on the current status. The 2024 Final Rule became effective on November 22, 2024, with staggered applicability dates beginning January 1, 2025. In May 2025 the Departments announced non-enforcement of the portions new relative to the 2013 rule, but the statute itself, the 2013 rule, and the CAA 2021 NQTL comparative analysis requirement all remain in force, and the MHPAEA statute requires DOL and HHS to conduct at least 20 investigations per year each. Operators who wrote off parity in 2025 are going to regret it.
The M&A Picture That Was Actually Forming in October 2024
The other October 2024 storyline: consolidation was uneven, not dead. VMG Health data showed behavioral health deals were up approximately 6% year-to-date through September 2024 compared to the same period in 2023, with volume driven by outpatient mental health platforms, stabilizing labor costs, and telehealth. Not a boom. Not a collapse. A reset.
In that same month, Acadia Healthcare announced the acquisition of three additional comprehensive treatment centers in Clinton, Easley, and Ridgeland, South Carolina, bringing its CTC division to 165 brick-and-mortar locations treating over 72,000 patients across 33 states. Acadia CEO Chris Hunter said “South Carolina is an underserved market with clear, unmet treatment demand for those suffering from opioid use disorder”. That is a strategic buyer picking off OTP density in a state where the demand story is easy to underwrite. Founders sitting on a single-site OTP in an underserved county should have been running a feasibility refresh in October 2024, not pitching a 12x EBITDA multiple.
By year end, Mertz Taggart reported 155 total transactions across behavioral health in 2024, with 37 in Q4 alone, and 36 addiction treatment provider transactions overall, up modestly from 29 in 2023. Modest. The buyers who moved in October moved on clean assets with real payer contracts and clean audit trails. The rest sat.
The Federal Enforcement Backdrop Every Operator Should Read Twice
The DOJ posture on behavioral health has hardened. The Department of Justice unveiled charges against 455 defendants for schemes totaling more than $6.5 billion in false claims, with Medicaid alone accounting for a record 295 defendants and more than $518 million in false claims. Included in that takedown: a $49 million Virginia Medicaid fraud scheme in which the co-owner of a mental health company allegedly targeted homeless individuals with hotel-stay bribes to bill for crisis stabilization services that were not needed or provided, and a $44 million Arizona case for fraudulent behavioral services primarily targeting Native Americans struggling with substance abuse.
Acting Attorney General Todd Blanche called it “the greatest whole-of-government effort to combat health care fraud in our Nation’s history”. Whatever you think of the rhetoric, the operational fact for buyers is this: CMS suspended 1,079 providers and revoked billing privileges for 1,403 providers as part of the same effort. If you are buying a treatment center, your diligence has to include an OIG exclusion sweep on every owner, every clinical director, and every historical medical director. I have watched deals die at day 45 because a founder forgot they had a cousin on the board who had been excluded a decade earlier.
What This Means If You Are Operating, Buying, or Selling Right Now
Three things I would tell any operator, buyer, or founder in the AHS orbit reading behavioral health news from this window:
- Rebuild your payer file around parity. Track denial rates by level of care and by CPT. Under the ASAM Criteria 4th Edition, be precise about what level of care you are billing (2.1 IOP, 2.5 PHP as an outpatient level, 3.5 residential, 3.7 residential detoxification). If a payer is denying your residential authorizations at rates materially higher than they deny med/surg inpatient in the same market, that is a parity conversation with a paper trail.
- Treat SAMHSA’s demand data as underwriting input, not marketing copy. The 2024 NSDUH found 23.4% of adults, or 61.5 million people, had any mental illness in the past year, and among people 12 or older classified as needing substance use treatment, only about 1 in 5, or 10.2 million people, received it. That is a treatment gap, not just a total addressable market slide.
- Assume your buyer, or your regulator, will read the DOJ takedown announcements. Clean chart audits, tight ownership disclosures, honest census reporting. If your growth curve looks too smooth, someone is going to ask why.
The through line from the MHPAEA rule, the M&A data, the NSDUH, and the DOJ takedown is the same. Federal agencies and sophisticated buyers are getting better at reading the operational signal. Operators who invested in the compliance program and the operational backbone in October 2024 are the ones getting priced fairly in 2026.
Frequently asked questions
Is the MHPAEA 2024 Final Rule still in effect for behavioral health operators?
The 2024 Final Rule became effective November 22, 2024, but in May 2025 the Departments of Labor, HHS, and Treasury announced a non-enforcement policy for the portions of the rule that are new relative to the 2013 final rule, pending litigation plus 18 months. The 2013 rule, the underlying MHPAEA statute, and the Consolidated Appropriations Act 2021 NQTL comparative analysis requirement all remain in force, and the statute requires DOL and HHS to each conduct at least 20 MHPAEA investigations per year. Operators should keep tracking NQTL and denial data at the level-of-care and CPT level.
How active was behavioral health M&A in 2024 and where did buyers focus?
Per VMG Health, deal volume was up approximately 6% year-to-date through September 2024 versus the same period in 2023, driven by outpatient mental health platforms and telehealth. Mertz Taggart counted 155 total transactions in 2024, including 37 in Q4 and 36 addiction treatment provider transactions for the year. Strategic buyers like Acadia Healthcare continued to consolidate opioid treatment programs, including three additional CTCs in South Carolina announced in October 2024.
What does the federal enforcement trend mean for a treatment center diligence process?
The DOJ’s June 2025 takedown of 455 defendants for $6.5 billion in alleged fraud, including specific behavioral health cases in Virginia ($49M) and Arizona ($44M), tells buyers that Medicaid behavioral health fraud is a top enforcement priority. CMS suspended 1,079 providers and revoked billing privileges for 1,403 more as part of that action. Buyer diligence should include OIG exclusion checks on all owners and clinical leadership, chart-level audit sampling, and validation that census and billing patterns tie to actual services delivered.
What SAMHSA data should operators use to underwrite a new treatment center?
The 2024 NSDUH found that 23.4% of adults (61.5 million people) had any mental illness in the past year and that only about 19.3% (roughly 10.2 million people) of those aged 12 or older who needed substance use treatment received it. That treatment gap, broken out by state and demographic in the NSDUH detailed tables, is a more defensible input for a pro forma than generic prevalence estimates and should be paired with local payer mix and licensure feasibility analysis.
References
- U.S. Department of Labor, Fact Sheet: Final Rules under the Mental Health Parity and Addiction Equity Act (MHPAEA), September 9, 2024
- DOL, HHS, and Treasury Joint Statement Regarding Enforcement of the MHPAEA 2024 Final Rule
- VMG Health, 2024 Review of Behavioral Health M&A Transactions & Trends
- Mertz Taggart, Q4 2024 Behavioral Health M&A Report
- U.S. Department of Justice, National Health Care Fraud Takedown Press Release
- Fierce Healthcare, DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- SAMHSA, Release of the 2024 National Survey on Drug Use and Health
- Slevin & Hart, P.C., Departments Issue Long-Awaited Final Rule on Mental Health Parity
- Trucker Huss, What Plan Sponsors Need to Know About the MHPAEA Final Rule